The Annual Scientific Session of the American Society of Nuclear Cardiology is Sept. 6-9, 2018, at the San Francisco Marriott Marquis.
A discussion with Ruth Fisher, MBA, vice president of the Henry Ford Hospital structural heart program, and Janet Wyman, NP, program manager. They explain how Henry Ford has been able to build its program and work with hospitals throughout Michigan, including those with their own transcatheter aortic valve replacement (TAVR) programs. They said building relationships with referral centers as partners and ensuring the patients go back to their local physicians for followups and regular care is key.
Watch the related VIDEO: Overview of the Henry Ford Hospital Structural Heart Program.
The Annual Scientific Session of the American Society of Nuclear Cardiology is Sept. 6-9, 2018, at the San Francisco Marriott Marquis.
A discussion with Patricia Dickson, LRT(CT), director of imaging and outpatient services, Capital Cardiology Associates, Albany, N.Y., and Nikki Weber, a lead CT technologist at the Mayo Clinic, Rochester, Minn. They presented in sessions at the Society of Cardiovascular Computed Tomography (SCCT) 2018 meeting.
Ed Nicol, M.D., FSCCT, MBA, head of cardiac CT, Royal Brompton Hospital, London, and chair of the Society of Cardiovascular Computed Tomography (SCCT) Education Committee. He outlined new initiatives by SCCT to expand its educational offerings. For more information on SCCT's online educational links go to https://scct.org/page/Education.
Link to the technologist video referenced in this interview that is among the most viewed videos on DAIC — VIDEO: How to Prepare a Patient for a Cardiac CT Scan.
Kavitha Chinnaiyan, M.D., FACC, FSCCT, associate professor, Oakland University, William Beaumont School of Medicine, Royal Oak, Mich. She presented at the Society of Cardiovascular Computed Tomography (SCCT) 2018 meeting.
Related FFR-CT Content:
VIDEO: Implementation and the Science Behind FFR-CT — interview with James Min, M.D.
VIDEO: Early U.S. Experience With FFR-CT in Evaluating ED Chest Pain Presentation — interview with Simon Dixon, M.D.
VIDEO: Status of FFR-CT Adoption in the United States — interview with Campbell Rogers, M.D.
Suhny Abbara, M.D., FSCCT, chief of cardiothoracic imaging and chair of the CT operations committee, University of Texas Southwestern Medical Center, Dallas, incoming president of the Society of Cardiovascular Computed Tomography (SCCT), and editor of the new RSNA journal Radiology: Cardiothoracic Imaging. He spoke to DAIC at SCCT 2018 meeting.
A discussion with Gianluca Pontone, M.D., Ph.D., FSCCT, director of cardiovascular MRI, Centro Cardiologico Manzino, Milan, Italy, at the Society of Cardiovascular Computed Tomography (SCCT) 2018 meeting. He said CT can be comparable to the gold-standards of nuclear and MRI perfusion depending on the scanner used to acquire the images.
Jonathon Leipsic, M.D., FSCCT, professor of radiology and cardiology at the University of British Columbia, Vancouver, Canada, and an expert in transcatheter valve imaging. He spoke about his experiences with TAVR and TMVR trials and devices planning at the the Society of Cardiovascular Computed Tomography (SCCT) 2018 meeting.
Read the related article "The Essentials of Structural Heart Imaging."
An interview with Patrick Serruys, M.D., Ph.D., Imperial College London, principal investigator of the SYNTAX III Trial presented earlier this year as a late-breaker at EuroPCR. He presented the trial again at the Society of Cardiovascular Computed Tomography (SCCT) 2018 meeting.
A discussion with Todd Villines, M.D., FACC, FAHA, FSCCT, director of cardiovascular research and cardiac CT programs at the Walter Reed National Military Medical Center in Bethesda, Md., and president of the Society of Cardiovascular Computed Tomography (SCCT). He outlines key technology trends at the 2018 SCCT meeting.
Read the article "New Cardiovascular CT Technology Entering the Market."
Ori Ben-Yehuda, M.D., executive director of the Cardiovascular Research Foundation Clinical Trial Center, discusses the latest data from clinical trials focusing on transcatheter tricuspid valve repair (TTVR) technologies, at the 2018 Transcatheter Valve Therapies (TVT) annual meeting in Chicago.
Related Transcatheter Tricuspid Valve Content
DAIC Editor Dave Fornell highlights some of the most innovative new technology on the show floor of the American Society of Echocardiography (ASE) 2018 meeting. The segments include virtual reality workstations, advanced 3-D cardiac ultrasound quantification and visualization, improved echo-fluoro image fusion technology, and imaging aided by artificial intelligence.
Partho Sengupta, M.D., DM, FACC, FASE, chief division of cardiology, director of cardiac imaging, West Virginia University Heart and Vascular Institute, explains how artificial intelligence is being integrated into echocardiography and used to mine big data to better assess patients at the American Society of Echocardiography (ASE) 2018 meeting.
Watch the VIDEO: Ultrasound's Integration of Artificial Intelligence and Robotic Echo, with Senguta at the ASE 2017 meeting
Rebecca Hahn, M.D., professor of medicine and director of interventional echocardiography, Columbia University Medical Center, New York, explains that techniques for imaging the tricuspid valve, the advanced study of its disease etiology and the rapid development of transcatheter devices to treat tricuspid valve disease are all developing together. She spoke on these topics during sessions at both the American Society of Echocardiography (ASE) 2018 meeting and at the Transcatheter Valve Therapies (TVT) conference in June.
Related Transcatheter Tricuspid Valve Content:
Recent Advances in Transcatheter Valve Technology
VIDEO: Mitral and Tricuspid Valve Repair Technologies — interview with Azeem Latib, M.D.
VIDEO: Transcatheter Tricuspid Valve Repair and Replacement Technologies — interview with Rebecca Hahn, M.D.
Malissa Wood, M.D., co-director of the Corrigan Women’s Heart Health Program, Massachusetts General Hospital, explains the need for and how to create a women’s cardiovascular health center, during the American Society of Echocardiography (ASE) 2018 meeting.
Find more women's health cardiac-related content in DAIC's Women's Health website channel.
Malissa Wood, M.D., co-director of the Corrigan Women’s Heart Health Program, Massachusetts General Hospital, explains the the recent debate and data for screening all student athletes for SCA during the American Society of Echocardiography (ASE) 2018 meeting.
Michael Lanspa, M.D., director of critical care echocardiography services, Intermountain Medical Center, Salt Lake City, Utah, explains the training initiatives by the American Society of Echocardiography (ASE) for point-of-care ultrasound. Lanspa serves on the educational committees for ASE, the American Thoracic Society (ATS) and the Society of Critical Care Medicine.
Lissa Sugeng, M.D., associate professor of medicine, director of echocardiography and of the Yale Echo Core Lab, Yale School of Medicine, explains the advances and advantages of using 3-D cardiac ultrasound during the American Society of Echocardiography (ASE) 2018 meeting. She said 3-D echo still has slower frame rates than 2-D, but offers some advantages. Sugeng said echo labs should consider adding at least 3-D machine, as this technology will become the way of the future in echo. Read more about recent advances in cardiac ultrasound.
This is an example of the a mitral valve with regurgitation imaged with 3-D echocardiography using the Siemens SC2000 cardiac ultrasound system. The first video clip shows the 3-D anatomy of the heart, the mitral valve, its leaflet cusps tabled and the left ventricular outflow track (LVOT) of the aortic valve. The second clip shows how the software can automatically extract and quantify the regurgitant volume. The last clip shows an isolation of the mitral valve and the regurgitant jet, showing the exact location of the source, which can be used aid surgical planning. This video was shot at the American Society of Echocardiography (ASE) 2018.
Sunil Mankad, M.D., FASE, ASE 2018 meeting program chair and director of transesophageal echocardiography at Mayo Clinic, Rochester, Minn., explains four big trends in cardiac ultrasound during the American Society of Echocardiography (ASE) 2018 meeting. These include the advancement of 3D echo, point-of-care ultrasound, artificial intelligence and new forms of image visualization. Read more about recent advances in cardiac ultrasound.
This is a demonstration of the the Philips TrueVue photo-realistic rendering and lighting source technology. This example highlights a transcatheter ASD closure with two Amplatzer occluders. The technology allows users to changing the lighting conditions to improve contrast. The light source can also be moved around to change the shadows and add more depth perception. The light source also can be pushed through the tissue to back light the anatomical structures, as shown in this example at the American Society of Echocardiography (ASE) 2018 meeting. The backlighting confirms a gap at the top of the image where part of the septal defect remains exposed.
Thomas Porter, M.D., professor of medicine and director of the echocardiography lab at the University of Nebraska Medical Center, discusses potential therapeutic uses for microbubble contrast ultrasound at the 2017 American Society of Echocardiography (ASE) annual meeting.
A new clinical trial at The Ohio State University Wexner Medical Center is examining an implanted device that uses vagus nerve stimulation to help stroke patients regain motor function. The Vivistim device is similar to a pacemaker, which uses leads to electrically stimulate the brain.
Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have integrated. He also explains how incorporation of his suburban hospital with Northwestern’s Bluhm Cardiovascular Institute has enabled a new TAVR program.
Read the related article on this hospital, "Hospital Consolidation May Increase Access to TAVR, New Cardiac Technologies."
ITN Associate Editor Jeff Zagoudis explores how the mobile stroke unit (MSU) program at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., is changing the paradigm of care for stroke patients in the western suburbs of Chicago and beyond.
Realted Mobile Stroke Content:
Organizations who are embarking on an enterprise imaging journey share many of the same questions and concerns regarding how to best optimize workflow across providers, departments and facilities; which technologies will provide the best fit for achieving the future vision; and how to maximize value and accelerate return on investment by driving adoption and improving satisfaction among providers and healthcare consumers (patients).
We, Paragon Consulting Partners LLC (PCP Imaging), are a team of passionate healthcare professionals that bring over 100 years of collective clinical, technical and business leadership experience within the healthcare IT and imaging informatics industries. In this video we address the key challenges and considerations faced by organizations undertaking an Enterprise Imaging journey, and how a trusted partner can contribute valuable expertise and guidance that enable healthcare organizations and vendors of any size to successfully tackle even their most challenging enterprise imaging initiatives. For more information, visit pcpimaging.com.
Northwestern Medicine has purchased several smaller Chicago suburban hospitals in the past few years to expand its healthcare system. This has enabled these smaller community hospitals to offer new, cutting-edge cardiovascular medical technologies much sooner than might have otherwise been possible due to its association with Northwestern Medicine's luminary Bluhm Cardiovascular Institute in Chicago. Central DuPage Hospital is one of the newer hospitals in the network and now offers transcatheter aortic valve replacements (TAVR), transcatheter leadless pacemakers, minimally invasive left atrial appendage (LAA) occlusions and the latest surgical valve replacement technologies.
Roxana Mehran, M.D., FACC, FACP, FCCP, FESC, FAHA, FSCAI, professor of medicine and director of interventional cardiovascular research and clinical trials at the Zena and Michael A. Wiener Cardiovascular Institute at Mount Sinai School of Medicine. She spoke on how to avoid acute kidney injury (AKI) and contrast-induced nephropathy (CIN) at the American College of Cardiology (ACC) 2018 meeting. Watch the VIDEO "How to Avoid Acute Kidney Injury in the Cath Lab," an interview with Hitinder Gurm, M.D.
A discussion with Ron Waksman, M.D., associate director of the division of cardiology and director of cardiovascular research and advanced education at MedStar Heart Institute, and professor of medicine (cardiology) at Georgetown University. He explained the ongoing clinical trials using near infrared spectroscopy to detect lipid rich plaque in the coronary arteries. He spoke to DAIC at the 2018 American College of Cardiology (ACC) meeting.
James Januzzi, M.D., Roman W. DeSanctis Endowed Distinguished Clinical Scholar in Medicine, and director of the Dennis and Marilyn Barry Fellowship in cardiology research at Massachusetts General Hospital, discusses the use of highly sensitive troponin testing for chest pain in the emergency department (ED). Read the related articles New Heart Attack Evaluation Cuts Unnecessary Tests, Time in ER and Highly-sensitive Troponin Test Can Detect Myocardial Injury After Non-Cardiac Surgery.
David Lanfear M.D., FACC, head of advanced heart failure and cardiac transplantation, Henry Ford Hospital, Detroit, discusses LVAD support technologies at the 2018 American College of Cardiology (ACC) meeting. Read the article “Device Technologies to Reduce Heart Failure Readmissions.” Watch the VIDEO “Technologies to Reduce Heart Failure Readmissions,” an interview with William Abraham, M.D., The Ohio State University Wexner Medical Center.
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at the 2018 meeting of the American College of Cardiology (ACC). Find links to other videos and the ACC 2018 Late-Breaking Trials.
A discussion with Doreen DeFaria Yeh, M.D., associate director, Massachusetts General Hospital Adult Congenital Heart Disease Program and MGH Cardiovascular Disease and Pregnancy Service, at the 2018 American College of Cardiology (ACC) meeting. Read the article “Diagnostic Differences in Women’s Heart Health.” Watch the VIDEO “Creating a Cardio-Obstetrics Team.”
A discussion with Ami Bhatt, M.D., director of the adult congenital heart program and outpatient cardiology, Massachusetts General Hospital, at the 2018 American College of Cardiology (ACC) meeting. Here is some additional related content on adult congenital heart disease:
Insights from the STS/ACC TVT Transcatheter Valve Registry, presented at the American College of Cardiology (ACC) 2018 meeting by Sammy Elmariah, M.D., MPH, interventional structural heart disease, Massachusetts General Hospital. See the following related content for other insights into transcatheter aortic valve replacement technology:
A discussion with Hitinder Gurm, M.D., MBBS, FACC, professor, internal medicine, and associate chief clinical officer, University of Michigan Health System, at the 2018 American College of Cardiology (ACC) meeting. For more information, read the article "Understanding Contrast-Induced Nephropathy."
Watch the VIDEO "Strategies to Avoid Acute Kidney Injury Caused by Cath Lab Contrast," an interview with Roxana Mehran, M.D.
An economic analysis of the DEFINE-FLAIR study comparing FFR vs. iFR, found a cost savings of nearly $900. The late-breaking session was presented at the 2018 American College of Cardiology (ACC) meeting by Manesh Patel, M.D., investigator and member of the study steering committee, and chief, division of cardiology, Duke University. Read more about the economic study. Watch a VIDEO on the 2017 results of the DEFINE-FLAIR and SWED-HEART iFR vs. FFR trials.
The Zoll LifeVest is a temporary, wearable defibrillator designed as a safety net for patients, especially those being evaluated for a permanent implantable cardioverter defibrillator (ICD). The Vest Prevention of Early Sudden Death Trial (VEST), presented at ACC 2018, was the first randomized, controlled, multi-center trial of the wearable cardioverter defibrillator. It looked to see if this device could effectively reduce sudden death in patients who had recently suffered a heart attack and had reduced heart function. Read more about the VEST Trial.
Sammy Elmariah, M.D., MPH, interventional structural heart disease, Massachusetts General Hospital, discusses the progression of using transcatheter heart valves to replace surgical valves at ACC.17. See the following related content for other insights into transcatheter aortic valve replacement technology:
This video details the first use of a new protocol at The Ohio State University’s Wexner Medical Center to start sudden cardiac arrest patients on extracorporeal membrane oxygenation (ECMO) en route to the hospital, where they are sent straight to the cath lab. According to the hospital, the protocol has improved cardiac arrest survival rates from 0 to nearly 40 percent. Video courtesy of The Ohio State University Wexner Medical Center.
The father of transradial artery access, Ferdinand Kiemeneij, M.D., Ph.D., interventional cardiologist, The Netherlands, explains how and why he first implemented the use of radial access and explains how the technique expanded beyond his cath lab to spread around the world. Read the article "Transradial Access Celebrates 25 Years". Watch the VIDEO "New Frontiers in Radial Access." Keep up to date on radial access news with DAIC's radial access channel.